Glenn Davis

Glenn Davis is an experienced professional in the biotechnology and pharmaceuticals sector, currently serving as Vice President of Portfolio and Program Management at Allogene Therapeutics since July 2024. Previously, Glenn held key leadership roles in program management at Replay, Arrowhead Pharmaceuticals, Kite Pharma, Takeda, and Amgen, contributing to projects within cell therapy, gastrointestinal therapeutics, and digital health initiatives. Glenn's career began with research internships at the Mayo Clinic and the University of Virginia. Educational qualifications include an MBA in International Business, Management, and Organizational Behavior, as well as a BS in Biology with an emphasis on Molecular Biology and Biochemistry, both from California Lutheran University.